{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:06:02Z","timestamp":1784761562090,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"3M Europe"},{"DOI":"10.13039\/100004343","name":"3M","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004343","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"DOI":"10.1186\/s13756-026-01767-y","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:54:03Z","timestamp":1779710043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An international randomised controlled trial of a novel antimicrobial dressing for peripheral intravenous catheters (ProP trial)"],"prefix":"10.1186","volume":"15","author":[{"given":"Bertrand","family":"Drugeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daner L","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia M","family":"Kleidon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Mihala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A","family":"Schults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Guenezan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Batiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Lopes","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mimoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M","family":"Rickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"5","key":"1767_CR1","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.12788\/jhm.3039","volume":"13","author":"E Alexandrou","year":"2018","unstructured":"Alexandrou E, et al. Use of short peripheral intravenous catheters: characteristics, management, and outcomes worldwide. J Hosp Med. 2018;13(5):E1\u20137.","journal-title":"J Hosp Med"},{"issue":"3","key":"1767_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/NAN.0000000000000326","volume":"42","author":"RE Helm","year":"2019","unstructured":"Helm RE, et al. Accepted but unacceptable: peripheral IV catheter failure. J Infus Nurs. 2019;42(3):151\u201364.","journal-title":"J Infus Nurs"},{"key":"1767_CR3","doi-asserted-by":"publisher","first-page":"104673","DOI":"10.1016\/j.ijnurstu.2023.104673","volume":"151","author":"N Marsh","year":"2024","unstructured":"Marsh N, et al. Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis. Int J Nurs Stud. 2024;151:104673.","journal-title":"Int J Nurs Stud"},{"key":"1767_CR4","doi-asserted-by":"publisher","unstructured":"Rickard CM et al. Infection risk of peripheral intravenous catheters \u2013 meta-synthesis of 18 prospective studies with 14,606 catheters. Antimic Resist & Infect Control, 2025;14(1):129. https:\/\/doi.org\/10.1186\/s13756-025-01645-z","DOI":"10.1186\/s13756-025-01645-z"},{"issue":"1","key":"1767_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1186\/s12879-017-2536-0","volume":"17","author":"A Sato","year":"2017","unstructured":"Sato A, et al. Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study. BMC Infect Dis. 2017;17(1):434.","journal-title":"BMC Infect Dis"},{"key":"1767_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jhin.2023.02.012","volume":"135","author":"B Drugeon","year":"2023","unstructured":"Drugeon B, et al. Incidence, complications, and costs of peripheral venous catheter-related bacteraemia: a retrospective, single-centre study. J Hosp Infect. 2023;135:67\u201373.","journal-title":"J Hosp Infect"},{"key":"1767_CR7","unstructured":"WHO. Guidelines for the Prevention of Bloodstream Infections and Other Infections Associated with the use of Intravascular Catheters. Part 1: peripheral catheters. Geneva; 2024. pp. 1\u2013140."},{"key":"1767_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13756-019-0581-8","volume":"8","author":"I Blanco-Mavillard","year":"2019","unstructured":"Blanco-Mavillard I, et al. Incidence of peripheral intravenous catheter failure among inpatients: variability between microbiological data and clinical signs and symptoms. Antimicrob Resist Infect Control. 2019;8:124.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"10","key":"1767_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.5694\/mja12.11699","volume":"198","author":"RL Stuart","year":"2013","unstructured":"Stuart RL, et al. Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services. Med J Aust. 2013;198(10):551\u20133.","journal-title":"Med J Aust"},{"issue":"12","key":"1767_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1164\/rccm.201206-1038OC","volume":"186","author":"JF Timsit","year":"2012","unstructured":"Timsit JF, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186(12):1272\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1767_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jama.2009.376","volume":"301","author":"J-F Timsit","year":"2009","unstructured":"Timsit J-F, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a RCT. JAMA. 2009;301(12):1231\u201341.","journal-title":"JAMA"},{"key":"1767_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/NAN.0000000000000532","volume":"47","author":"B Nickel","year":"2024","unstructured":"Nickel B, et al. Infusion therapy standards of practice. J Infus Nurs. 2024;47:S1\u2013285.","journal-title":"J Infus Nurs"},{"issue":"5","key":"1767_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1017\/ice.2022.87","volume":"43","author":"N Buetti","year":"2022","unstructured":"Buetti N, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol. 2022;43(5):553\u201369.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"1767_CR14","doi-asserted-by":"publisher","first-page":"e084313","DOI":"10.1136\/bmjopen-2024-084313","volume":"14","author":"CM Rickard","year":"2024","unstructured":"Rickard CM, et al. Protect peripheral intravenous catheters: a study protocol for a randomised controlled trial of a novel antimicrobial dressing for peripheral intravenous catheters (ProP trial). BMJ Open. 2024;14(7):e084313.","journal-title":"BMJ Open"},{"key":"1767_CR15","doi-asserted-by":"crossref","unstructured":"Hopewell S, Collins CA, Hr\u00f3bjartsson GS, Moher A, Schulz D, Tunn KF, Aggarwal R, Berkwits R, Berlin M, Bhandari JA, Butcher N, Campbell NJ, Chidebe MK, Elbourne RCW, Farmer D, Fergusson A, Golub DA, Goodman RM, Hoffmann SN, Ioannidis TC, Kahan JPA, Knowles BC, Lamb RL, Lewis SE, Loder S, Offringa E, Ravaud M, Richards P, Rockhold DP, Schriger FW, Siegfried DL, Staniszewska NL, Taylor S, Thabane RS, Torgerson L, Vohra D, White S, Boutron IR. I., In: CONSORT 2025 statement: updated guideline for reporting randomised trials. Lancet, 2025(25): pp. 00672\u20135.","DOI":"10.1136\/bmj-2024-081123"},{"key":"1767_CR16","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Minor TR, Elliott BL, Fernandez V, O\u2019Neal M, McLeod L, Delacqua L, Delacqua G, Kirby F, Duda J. REDCap Consortium., The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"key":"1767_CR17","unstructured":"Australian Commission on Safety and Quality in Health Care. Management of Peripheral Intravenous Catheters Clinical Care Standard 2021, ACSQHC: Sydney."},{"issue":"10145","key":"1767_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(18)31380-1","volume":"392","author":"CM Rickard","year":"2018","unstructured":"Rickard CM, et al. Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial. Lancet. 2018;392(10145):419\u201330.","journal-title":"Lancet"},{"issue":"1","key":"1767_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-10-1","volume":"10","author":"L Thabane","year":"2010","unstructured":"Thabane L, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1767_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jtv.2020.03.006","volume":"29","author":"TM Kleidon","year":"2020","unstructured":"Kleidon TM, et al. Smile\u2014secure my intravenous line effectively: a pilot randomised controlled trial of peripheral intravenous catheter securement in paediatrics. J Tissue Viability. 2020;29(2):82\u201390.","journal-title":"J Tissue Viability"},{"issue":"2","key":"1767_CR21","doi-asserted-by":"publisher","first-page":"e13110","DOI":"10.1111\/ijn.13110","volume":"29","author":"N Marsh","year":"2023","unstructured":"Marsh N, et al. Safety and efficacy of midline catheters versus peripheral intravenous catheters: a pilot randomized controlled trial. Int J Nurs Pract. 2023;29(2):e13110.","journal-title":"Int J Nurs Pract"},{"issue":"1","key":"1767_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-023-02217-8","volume":"22","author":"EN Larsen","year":"2024","unstructured":"Larsen EN, et al. Health-related quality of life and experience measures, to assess patients\u2019 experiences of peripheral intravenous catheters: a secondary data analysis. Health Qual Life Outcomes. 2024;22(1):1.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"1767_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/11297298211023274","volume":"24","author":"M Pittiruti","year":"2023","unstructured":"Pittiruti M, Scoppettuolo VBT, Carr G, Konstantinou P, Ortiz Miluy E, Lamperti G, Goossens M, Simcock GA, Dupont L, Inwood C, Bertoglio S, Nicholson S, Pinelli J, Pepe F. European recommendations on the proper indication and use of peripheral venous access devices (the ERPIUP consensus): a WoCoVA project. J Vasc Access. 2023;24(1):165\u201382.","journal-title":"J Vasc Access"},{"issue":"1","key":"1767_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, et al. Clinical practice guidelines for diagnosis & management of intravascular catheter-related infection: infectious diseases society of America. Clin Infect Dis. 2009;49(1):1\u201345.","journal-title":"Clin Infect Dis"},{"key":"1767_CR25","unstructured":"Centers for Disease Control and Prevention, Promotion DoHQ. National Healthcare Safety Network (NHSN) Patient Safety Component Manual. Centers of Disease Control and Prevention: Atlanta, Georgia; 2021."},{"key":"1767_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/nur.20247","volume":"31","author":"M Hertzog","year":"2008","unstructured":"Hertzog M. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31:180\u201391.","journal-title":"Res Nurs Health"},{"issue":"1","key":"1767_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jhm.12995","volume":"18","author":"CM Rickard","year":"2023","unstructured":"Rickard CM, et al. Integrated versus nonintegrated peripheral intravenous catheter in hospitalized adults (OPTIMUM): a randomized controlled trial. J Hosp Med. 2023;18(1):21\u201332.","journal-title":"J Hosp Med"},{"key":"1767_CR28","doi-asserted-by":"publisher","first-page":"104095","DOI":"10.1016\/j.ijnurstu.2021.104095","volume":"124","author":"N Marsh","year":"2021","unstructured":"Marsh N, et al. Peripheral intravenous catheter failure: a secondary analysis of risks from 11,830 catheters. Int J Nurs Stud. 2021;124:104095.","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"1767_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1086\/674398","volume":"35","author":"MC Wallis","year":"2014","unstructured":"Wallis MC, et al. Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial. Infect Control Hosp Epidemiol. 2014;35(1):63\u20138.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"1767_CR30","doi-asserted-by":"publisher","first-page":"ofw072","DOI":"10.1093\/ofid\/ofw072","volume":"3","author":"ED Austin","year":"2016","unstructured":"Austin ED, et al. Peripheral intravenous catheter placement is an underrecognized source of staphylococcus aureus bloodstream infection. Open Forum Infect Dis. 2016;3(2):ofw072.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"1767_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40121-019-00257-6","volume":"8","author":"K Tatsuno","year":"2019","unstructured":"Tatsuno K, et al. Clinical features of bloodstream infections associated with peripheral versus central venous catheters. Infect Dis Ther. 2019;8(3):343\u201352.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1767_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13756-024-01414-4","volume":"13","author":"B Drugeon","year":"2024","unstructured":"Drugeon B, et al. Insertion site and risk of peripheral intravenous catheter colonization and\/or local infection: a post hoc analysis of the CLEAN 3 study including more than 800 catheters. Antimicrob Resist Infect Control. 2024;13(1):57.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"9","key":"1767_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/pan.14229","volume":"31","author":"TM Kleidon","year":"2021","unstructured":"Kleidon TM, Wainwright SJ, Mihala C, Gibson G, Saiyed V, Byrnes M, Cattanach J, Macfarlane P, Graham F, Shevill N, Ullman E. Comparison of midline catheters and peripherally inserted central catheters to reduce the need for general anesthesia in children with respiratory disease: a feasibility randomized controlled trial. Paediatr Anaesth. 2021;31(9):985\u201395.","journal-title":"Paediatr Anaesth"},{"issue":"2","key":"1767_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/hpeds.2024-007894","volume":"15","author":"AG Burek","year":"2025","unstructured":"Burek AG, Plunk PK, Corey Bauer MR, Liegl S, Pan M, Flynn A, Brousseau KE, Gedeit DC, Ullman R. Comparing midline and peripherally inserted central catheters: a randomized feasibility trial. Hosp Pediatr. 2025;15(2):124\u201334.","journal-title":"Hosp Pediatr"},{"issue":"4","key":"1767_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.idh.2023.03.007","volume":"28","author":"N Marsh","year":"2023","unstructured":"Marsh N, O\u2019Brien LE, Groom C, Kleidon P, Alexandrou TM, Young E, McCarthy E, Rickard K. Comparing the use of midline catheters versus peripherally inserted central catheters for patients requiring peripherally compatible therapies: a pilot randomised controlled trial (the compact trial). Infect Dis Health. 2023;28(4):259\u201364.","journal-title":"Infect Dis Health"},{"key":"1767_CR36","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/CCM.0b013e3181920e33","volume":"37","author":"DM Arnold","year":"2009","unstructured":"Arnold DM, Adhikari BK, Kho NK, Meade ME, Cook MO, McMaster Critical Care Interest Group. The design and interpretation of pilot trials in clinical research in critical care. Crit Care Med. 2009;37:S69\u201374.","journal-title":"Crit Care Med"},{"issue":"1","key":"1767_CR37","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12879-019-4029-9","volume":"19","author":"L Wei","year":"2019","unstructured":"Wei L, et al. Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(1):429.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"1767_CR38","doi-asserted-by":"publisher","first-page":"pe0256336","DOI":"10.1371\/journal.pone.0256336","volume":"16","author":"S B","year":"2021","unstructured":"B. S. Has resistance to chlorhexidine increased among clinically-relevant bacteria? A systematic review of time course and subpopulation data. PLoS ONE. 2021;16(8):pe0256336.","journal-title":"PLoS ONE"},{"issue":"10","key":"1767_CR39","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/annonc\/mdw275","volume":"27","author":"LM Biehl","year":"2016","unstructured":"Biehl LM, et al. A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients. Ann Oncol. 2016;27(10):1916\u201322.","journal-title":"Ann Oncol"},{"issue":"6","key":"1767_CR40","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00134-019-05617-x","volume":"45","author":"P Eggimann","year":"2019","unstructured":"Eggimann P, et al. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years. Intensive Care Med. 2019;45(6):823\u201333.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1767_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jhin.2016.08.018","volume":"94","author":"G Kampf","year":"2016","unstructured":"Kampf G. Acquired resistance to chlorhexidine\u2014is it time to establish an \u2018antiseptic stewardship\u2019 initiative? J Hosp Infect. 2016;94(3):213\u201327.","journal-title":"J Hosp Infect"},{"issue":"1","key":"1767_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ajic.2015.08.022","volume":"44","author":"TJ Karpanen","year":"2016","unstructured":"Karpanen TJ, et al. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters. Am J Infect Control. 2016;44(1):54\u201360.","journal-title":"Am J Infect Control"},{"issue":"3","key":"1767_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10096-022-04403-w","volume":"41","author":"B Van den Poel","year":"2022","unstructured":"Van den Poel B, Saegeman V, Schuermans A. Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control. Eur J Clin Microbiol Infect Dis. 2022;41(3):349\u201362.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"1767_CR44","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4067\/s0716-10182017000400319","volume":"34","author":"TV VERGARA","year":"2017","unstructured":"VERGARA TV, Elena FICA, LEIVA A. Jordan., Flebitis infecciosa o no infecciosa: lecciones de un programa intervencional sobre flebitis asociada a cat\u00e9ter venoso perif\u00e9rico. Revista Chil de infectolog\u00eda. 2017;34(4):319\u201325.","journal-title":"Revista Chil de infectolog\u00eda"},{"issue":"12","key":"1767_CR45","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1111\/jan.14565","volume":"76","author":"N Marsh","year":"2020","unstructured":"Marsh N, et al. Peripheral intravenous catheter non-infectious complications in adults: a systematic review and meta-analysis. J Adv Nurs. 2020;76(12):3346\u201362.","journal-title":"J Adv Nurs"},{"issue":"3","key":"1767_CR46","first-page":"132","volume":"33","author":"S Ballesteros-Pe\u00f1a","year":"2022","unstructured":"Ballesteros-Pe\u00f1a S, et al. Identification of potentially irritating intravenous medications. Enferm Intensiva (Engl Ed). 2022;33(3):132\u201340.","journal-title":"Enferm Intensiva (Engl Ed)"},{"issue":"7","key":"1767_CR47","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S1473-3099(20)30738-6","volume":"21","author":"J Guenezan","year":"2021","unstructured":"Guenezan J, et al. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial. Lancet Infect Dis. 2021;21(7):1038\u201348.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1767_CR48","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/CCM.0b013e31824e0d46","volume":"40","author":"JF Timsit","year":"2012","unstructured":"Timsit JF, et al. Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med. 2012;40(6):1707\u201314.","journal-title":"Crit Care Med"},{"issue":"6","key":"1767_CR49","doi-asserted-by":"publisher","first-page":"e0269750","DOI":"10.1371\/journal.pone.0269750","volume":"17","author":"F Maunoury","year":"2022","unstructured":"Maunoury F, et al. Cost-effectiveness analysis of bundled innovative devices versus standard approach in the prevention of unscheduled peripheral venous catheters removal due to complications in France. PLoS ONE. 2022;17(6):e0269750.","journal-title":"PLoS ONE"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-026-01767-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01767-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-026-01767-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:51:42Z","timestamp":1784760702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13756-026-01767-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1767"],"URL":"https:\/\/doi.org\/10.1186\/s13756-026-01767-y","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by Ouest I ethic committee in France and by The Queensland Children\u2019s Hospital Human Research Ethics Committee in Australia. All participants, or representants, have given their written inform consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have given their permission for this article to be published. Participants have given their consent for publication upon providing written informed consent for participation in this trial. Results will be sent to participants if contact details were provided on the participants consent form.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OM, BD, and JG received funding for congress attendance, and research funding from Becton Dickinson and 3\u00a0M. DLB\u2019s employer (The University of Queensland) has received on her behalf unrestricted research grants from Becton Dickinson and Solventum and consultancy payments from BBraun. TMK\u2019s employer (The University of Queensland or Griffith University) has received unrestricted research grants on her behalf from BD, and consultancy payments from 3\u00a0M, BD, BBraun, Medical Specialties Australia, and Smiths Medical. NM\u2014Griffith University and The University of Queensland have received on her behalf investigator-initiated research grants or consultancies from Cardinal Health, Biolife, 3\u00a0M, Eloquest, Medline and Wolters Klewer. AJU\u2019s employer (The University of Queensland or Griffith University) has received unrestricted research grants or consultancies on her behalf from BD, 3\u00a0M, Sterile Care, and Medline. AC has received unrestricted investigator-initiated research grants, paid to her employer (Griffith University), from Cardinal Health, 3\u00a0M, and Eloquest. JB\u2019s employer (Griffith University) has received unrestricted research grants on his behalf from BD and Navi Technologies, and consultancy payments from 3\u00a0M and BD. CMR\u2019s employer (The University of Queensland or Griffith University) has received unrestricted research grants on her behalf from BD and Solventum, consultancy payments from Solventum, BD, BBraun, and ITL Biomedical, and the AVATAR group has received educational travel sponsorship from ICU Medical, Solventum and Spectrum Vascular. COB, GM, JS, and TLS have no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"94"}}